(NCLO) NuShares Trust - Ratings and Ratios
Exchange: US • Country: USA • Currency: USD • Type: Etf • • Bank Loan
NCLO: CLOs, CLO Tranches, Active Management, Fixed Income, Corporate Loans
The NuShares ETF Trust (NCLO) is an actively managed exchange-traded fund (ETF) designed to capitalize on the debt tranches of Collateralized Loan Obligations (CLOs). Under normal market conditions, the fund allocates at least 80% of its net assets and borrowings to CLO debt tranches rated between AA+ and BBB- by nationally recognized rating agencies. If unrated, the funds management team assesses these assets for comparable credit quality. The fund is non-diversified, meaning it can concentrate its holdings in fewer securities, which may amplify risk or return potential. CLOs are structured financial instruments that pool together leveraged loans, offering a senior position in the capital structure, which can provide a degree of protection against default. The funds focus on CLO debt tranches is appealing to investors seeking exposure to corporate credit with a layer of diversification across various industries and issuers.
As of the latest data, the fund has an average 20-day volume of 19,488 shares, with a last price of $25.04. Its short-term and long-term moving averages (SMA 20: $25.13, SMA 50: $25.03, SMA 200: $25.02) indicate a stable price trend, with minimal deviation. The Average True Range (ATR) of 0.04 reflects low volatility, suggesting the funds price movements are relatively contained. With assets under management (AUM) of $79.74 million, the fund operates at a moderate scale, balancing liquidity with focused exposure to the CLO market.
Additional Sources for NCLO ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NCLO ETF Overview
Market Cap in USD | 81m |
Category | Bank Loan |
IPO / Inception | 2024-12-10 |
NCLO ETF Ratings
Growth 5y | 21.6% |
Fundamental | - |
Dividend | 48.2% |
Rel. Strength Industry | 2.22 |
Analysts | - |
Fair Price Momentum | 23.46 USD |
Fair Price DCF | - |
NCLO Dividends
Dividend Yield 12m | 0.85% |
Yield on Cost 5y | 0.86% |
Annual Growth 5y | 18.71% |
Payout Consistency | 100.0% |
NCLO Growth Ratios
Growth Correlation 3m | 99.1% |
Growth Correlation 12m | 99.1% |
Growth Correlation 5y | 99.1% |
CAGR 5y | 1.29% |
CAGR/Max DD 5y | 0.00 |
Sharpe Ratio 12m | -7.12 |
Alpha | -3.10 |
Beta | 0.03 |
Volatility | 3.17% |
Current Volume | 29.5k |
Average Volume 20d | 7.8k |
As of March 12, 2025, the stock is trading at USD 25.05 with a total of 29,511 shares traded.
Over the past week, the price has changed by +0.02%, over one month by +0.14%, over three months by +1.29% and over the past year by +1.29%.
Neither. Based on ValueRay Analyses, NuShares Trust is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 21.62 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NCLO as of March 2025 is 23.46. This means that NCLO is currently overvalued and has a potential downside of -6.35%.
NuShares Trust has no consensus analysts rating.
According to ValueRays Forecast Model, NCLO NuShares Trust will be worth about 25.3 in March 2026. The stock is currently trading at 25.05. This means that the stock has a potential upside of +1.16%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.3 | 1.2% |